Our Pipeline

Cancer Therapeutics CRC advances promising targets by committing our full suite of infrastructure, equipment and skills to the three phases of early drug discovery and development: hit discovery, lead generation and lead optimisation.

Our Current Pipeline

Diagram outlining current cancer research projects and their milestones

Commercial Collaborations and Licensing Deals

In specific cases, we will partner with commercial entities to move programs forward into clinical development.

Cancer Therapeutics CRC has executed four preclinical licensing deals and three multi-year research collaborations with pharmaceutical companies.

Partners include the following organisations:

Pharmaceutical company that has partnered with Cancer Therapeutics CRC
Pharmaceutical company that has partnered with Cancer Therapeutics CRC
Pharmaceutical company that has partnered with Cancer Therapeutics CRC